ALS Ltd (ASX: ALQ) Share Price and News

Price

$16.88

Movement

0.02 (+0.12%)

as at 16 Jun - Closed (20 mins delayed)

52 Week Range

$13.09 - $18.19

 
1 Year Return

+19.55%

ALS Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $8.53 billion
P/E Ratio 31.66
Dividend Yield 2.32%
Shares Outstanding 505.83 million
Earnings per share 0.525
Dividend per share 0.39
Year To Date Return 10.21%
Earnings Yield 3.16%
Franking 30
Share Price

$16.88

Day Change

0.02 (+0.12%)

52 Week Range

$13.09 - $18.19

Yesterday's Close

$16.86

Today's Open

$16.78

Days Range

$16.71 - $16.96

Volume

949,243

Avg. Volume (1 month)

1,446,189

Turnover

$16,014,736

as at 16 Jun - Closed

  • ALS Ltd (ASX: ALQ)
    Latest News

    A young man sits at his desk working on his laptop with a big smile on his face.
    Broker Notes

    Brokers name 3 ASX shares to buy today

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    man thinking about whether to invest in bitcoin
    Broker Notes

    Why Macquarie expects this ASX 200 dividend stock to keep outperforming

    Macquarie has tipped this ASX 200 dividend stock to outperform. Let’s find out why.

    Read more »

    Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
    Share Fallers

    Why ALS, Black Cat, Boss Energy, and Soul Patts shares are falling today

    These shares are falling on Thursday. Let's find out why.

    Read more »

    Frustrated and shocked business woman reading bad news online from phone.
    Broker Notes

    Guess which ASX 200 share Goldman Sachs just downgraded

    The broker is calling time on this stock's rally.

    Read more »

    Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
    Share Fallers

    Why ALS, Fisher & Paykel Healthcare, IPD, and Predictive Discovery shares are falling today

    These shares are having a tough time on hump day. But why?

    Read more »

    A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
    Industrials Shares

    Key takeaways from ALS shares results according to Macquarie

    ALS announced an underlying net profit after tax (NPAT) of $312 million this week.

    Read more »

    Five businessmen in suits walking up stairs in neat succession.
    52-Week Highs

    5 ASX 200 shares smashing new 52-week highs today

    These five ASX 200 shares just broke into new multi-year and all-time highs. Here’s why.

    Read more »

    Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
    52-Week Highs

    5 ASX 200 shares hitting multi-year highs after strongly rebounding from tariff turmoil

    These stocks have hit new price milestones amid a day in the green for the ASX 200.

    Read more »

    Man smiling on top of rocks with mountains in the background.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    Investors started the week on a strong footing today.

    Read more »

    A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
    Broker Notes

    Leading brokers name 3 ASX shares to buy today

    Here's why brokers believe that now could be the time to snap up these shares.

    Read more »

    Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
    Share Gainers

    Why ALS, Life360, Nuix, and Sovereign Metals shares are pushing higher today

    These shares are having a good start to the week. But why?

    Read more »

    Person pointing at an increasing blue graph which represents a rising share price.
    Broker Notes

    Top broker says this ASX 200 share is a buy for a 10%+ return

    Goldman Sachs has good things to say about this share.

    Read more »

    Frequently Asked Questions

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    27 Nov 2024 $0.1890 30.00% Interim 19 Dec 2024
    12 Jun 2024 $0.1960 20.00% Final 02 Jul 2024
    23 Nov 2023 $0.1960 20.00% Interim 14 Dec 2023
    09 Jun 2023 $0.1940 10.00% Final 06 Jul 2023
    24 Nov 2022 $0.2030 0.00% Interim 16 Dec 2022
    06 Jun 2022 $0.1700 30.00% Final 04 Jul 2022
    02 Dec 2021 $0.1580 30.00% Interim 17 Dec 2021
    07 Jun 2021 $0.1460 70.00% Final 05 Jul 2021
    26 Nov 2020 $0.0850 100.00% Interim 16 Dec 2020
    05 Jun 2020 $0.0610 70.00% Final 06 Jul 2020
    27 Nov 2019 $0.1150 30.00% Interim 16 Dec 2019
    03 Jun 2019 $0.1150 35.04% Final 01 Jul 2019
    29 Nov 2018 $0.1100 20.00% Interim 18 Dec 2018
    06 Jun 2018 $0.0900 40.00% Final 02 Jul 2018
    29 Nov 2017 $0.0800 40.00% Interim 18 Dec 2017
    07 Jun 2017 $0.0000 0.00% Final 03 Jul 2017
    05 Dec 2016 $0.0550 60.00% Interim 21 Dec 2016
    08 Jun 2016 $0.0600 40.00% Final 01 Jul 2016
    03 Dec 2015 $0.0750 25.07% Interim 18 Dec 2015
    11 Jun 2014 $0.2000 50.00% Final 02 Jul 2014
    07 Jun 2013 $0.2700 50.00% Final 02 Jul 2013
    05 Jun 2009 $0.4250 0.00% Final 01 Jul 2009
    01 Dec 2008 $0.4250 58.82% Interim 17 Dec 2008
    06 Jun 2008 $0.5100 58.82% Final 01 Jul 2008
    30 Nov 2007 $0.2975 58.82% Interim 17 Dec 2007
    06 Jun 2007 $0.3570 58.82% Final 02 Jul 2007
    29 Nov 2006 $0.2380 58.82% Interim 15 Dec 2006
    05 Jun 2006 $0.2900 100.00% Final 03 Jul 2006
    25 Nov 2005 $0.2100 100.00% Interim 20 Dec 2005
    04 Jun 2004 $0.1900 100.00% Final 01 Jul 2004
    28 Nov 2003 $0.1400 100.00% Interim 19 Dec 2003

    ALQ ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About ALS Ltd

    ALS Ltd (ASX: ALQ) is one of the world's largest laboratory testing, inspection, certification, and verification businesses. It operates from around 350 sites across 65 countries.

    Listed on the ASX in 1952, ALS operates three divisions: commodities, life sciences, and industrial. ALS's commodities segment traditionally generates the majority of the company's underlying earnings. It provides geochemistry, metallurgy, inspection, and mine site services for the mining industry globally.

    The company also provides environmental, pharmaceutical, and food and beverage testing and certification. ALS Ltd has a multi-billion dollar market capitalisation and is part of the ASX 100.

    ALQ Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Jun 2025 $16.86 $0.24 1.44% 1,063,494 $16.64 $16.91 $16.64
    12 Jun 2025 $16.62 $-0.08 -0.48% 1,279,857 $16.68 $16.78 $16.45
    11 Jun 2025 $16.70 $0.00 0.00% 1,211,470 $16.89 $16.99 $16.68
    10 Jun 2025 $16.70 $0.25 1.52% 1,323,745 $16.53 $16.86 $16.47
    06 Jun 2025 $16.45 $0.01 0.06% 870,007 $16.41 $16.62 $16.32
    05 Jun 2025 $16.44 $0.24 1.48% 1,461,232 $16.26 $16.58 $16.22
    04 Jun 2025 $16.20 $0.12 0.75% 1,372,919 $16.14 $16.43 $16.06
    03 Jun 2025 $16.08 $0.03 0.19% 1,559,362 $16.11 $16.19 $15.97
    02 Jun 2025 $16.05 $-0.02 -0.12% 1,384,583 $16.07 $16.22 $15.97
    30 May 2025 $16.07 $-0.15 -0.92% 1,892,680 $16.11 $16.24 $16.00
    29 May 2025 $16.22 $-0.08 -0.49% 3,497,725 $16.20 $16.55 $16.03
    28 May 2025 $16.30 $-1.34 -7.60% 4,795,327 $16.50 $16.59 $16.00
    26 May 2025 $17.64 $-0.05 -0.28% 1,096,864 $17.71 $17.75 $17.48
    23 May 2025 $17.69 $-0.05 -0.28% 946,787 $17.35 $17.71 $17.22
    22 May 2025 $17.74 $-0.11 -0.62% 905,067 $17.58 $17.95 $17.48
    21 May 2025 $17.85 $0.03 0.17% 968,855 $17.93 $17.93 $17.62
    20 May 2025 $17.82 $0.11 0.62% 1,179,673 $17.72 $17.94 $17.58
    19 May 2025 $17.71 $-0.16 -0.90% 1,034,819 $17.71 $17.85 $17.62
    16 May 2025 $17.87 $0.13 0.73% 1,079,318 $17.91 $18.01 $17.63

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    25 Nov 2024 Peter Possemiers Buy 3,100 $50,902
    On-market trade.
    20 Nov 2024 Nigel Garrard Buy 3,950 $60,049
    On-market trade.
    08 Aug 2024 Nigel Garrard Buy 2,250 $33,412
    On-market trade.
    31 Jul 2024 Malcom Deane Issued 163,082 $2,304,360
    Issue of securities. 398,893 Rights
    01 Jul 2024 Malcom Deane Expiry 424 $5,952
    As advised by the company. 257,297 - Performance Rights
    424 Performance Rights forfeited
    01 Jul 2024 Malcom Deane Exercise 21,486 $301,663
    Conversion of securities. 2,35,811 - Performance Rights & Service Rights
    01 Jul 2024 Malcom Deane Issued 18,088 $253,955
    Issue of securities. 257,721 - Performance Rights
    As per announcement on 04/07/2024.
    01 Jul 2024 Malcom Deane Buy 21,486 $301,663
    Conversion of securities.
    28 Jun 2024 Nigel Garrard Buy 2,750 $39,595
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Nigel David Garrard Non-Executive Deputy ChairmanNon-Executive Director Jun 2023
    Mr Garrard is an executive with a record across the fast-moving consumer goods and industrial/manufacturing sectors. He has over 20 years of experience as an ASX-listed CEO across three companies. In 2019, he retired as Managing Director and CEO of Orora Limited. He led the demerger of Orora Limited from Amcor, and the subsequent listing of Orora Limited on ASX in 2013. He was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil's Food and Services Division, and Managing Director of SPC Ardmona. Nigel brings international experience across listed, not-for-profit, government and private entities. He is currently the Chairman of Ansell Limited, Chairman of Flinders Port Holdings Pty Ltd, Chairman of the McMahon Services advisory board, and Director of Treasury Wine Estates Limited.
    Dr John Francis Mulcahy Non-Executive Director Feb 2012
    Mr Mulcahy is Chairman of Orix Australia Corporation Limited, an unlisted public company (appointed March 2016). He is also a current Non-Executive Director of various Zurich Australia Insurance subsidiaries and GWA Group Limited. John was previously a director and Chairman of both Mirvac Group Limited (November 2009 - December 2022), Coffey International Limited (September 2009 - January 2016). He is a former Guardian of the Future Fund of Australia and former Managing Director and Chief Executive Officer of Suncorp-Metway Limited. Prior to Suncorp, John held several senior executive roles at the Commonwealth Bank and Lend Lease Corporation. He is a member of the Sustainability and Innovation Committee.
    Ms Tonianne Dwyer Non-Executive Director Jul 2016
    Ms Dwyer has experience as a company director and executive working in finance, corporate strategy and mergers and acquisitions across a variety of sectors and international markets. She is an internationally experienced independent company director, having had a 25-year executive career in investment banking during which she held roles with Hambros Bank Limited and Societe General in the UK and Europe. Tonianne currently holds a non-executive directorship role with Dyno Nobel, Growthpoint Properties Australia and AUB Group. Her previous roles included non-executive director positions with OZ Minerals Limited, DEXUS Property Group, DEXUS Wholesale Property Fund, Metcash Limited, Queensland Treasury Corporation and Cardno Limited. She is a member of the People Committee and Risk Committee.
    Ms Leslie A Desjardins Non-Executive Director Nov 2019
    Ms Desjardins has a background as a CFO and senior financial and governance professional in a range of large multinational and global businesses. She has commercial and financial governance expertise with large multinational public companies in North America, Canada, and Australia each with global operations. Her areas of expertise include CFO level executive and financial strategic leadership, M&A, corporate finance and treasury, governance, financial and tax compliance, and enterprise risk management. Leslie is currently a Director, Audit Committee Chair, Human Resource Committee member with Ansell Limited. During her executive career, Leslie served as Executive VP and CFO at Amcor Limited, a global leader in packaging of food, beverage, pharmaceutical and tobacco products. Prior to Amcor Ltd, Leslie served in financial and corporate strategic positions with General Motors Corporation, including Chief Financial Officer GM Holden Australia, Controller GM North America, Executive Director Manufacturing Finance and Director GM North America Strategy and Planning. She is the Chair of the Risk Committee and from April 2025 a member of the People Committee. In FY25, Leslie was a member of the Sustainability and Innovation Committee.
    Dr Siddhartha Kadia Non-Executive Director Jan 2019
    Mr Kadia is currently CEO and Director at Calibre Scientific, a privately held company that services life sciences tools industry. Siddhartha has lived and worked in the US, Japan, China, and India and has more than 20 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors. Siddhartha was formerly President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego, California. He has also been a Director of USA-listed companies Newport Corporation (NSDQ: NEWP), Volcano Corporation (NSDQ: VOLC), Isoplexis Corporation (NSDQ:ISO), Berkeley Lights (NDSQ:BLI), Horizon Discovery Group (LSW:HZD), Nuvasive, Inc (NSDQ: NUVA). Siddhartha was also a management consultant at McKinsey & Company where his work focused on various life sciences and healthcare related engagements. He is the Chair of the Sustainability and Innovation Committee, a member of the People Committee.
    Ms Erica Mann Non-Executive Director Mar 2024
    Ms Mann is a C-suite executive with a 30- year career across complex, highly regulated, multi-channel and multi-product environment in top DAX, NYSE, NSDAQ pharmaceutical, OTC and FMCG multinationals. Before retiring as an executive, Erica led Bayer's Consumer Health Division, one of the world's largest OTC companies with 6 billion euro in turnover. Prior to joining Bayer, she was President and General Manager of Pfizer Nutrition following its acquisition of Wyeth Inc, where she served as Senior Vice President of Global Nutrition. This followed the other senior executive roles of other Fortune 500 companies including Eli-Lily and Johnson & Johnson. She has held leadership positions in South Africa, Australia, New Zealand, Germany, Switzerland and the US. In addition to her executive experience in the nutrition and health industry, Erica has experience with global and emerging markets across Africa, China, Russia, and Brazil. Erica currently serves as an independent director of Kenvue, DSM-Firmenich and Kellogg where she is a member of the Audit, and Social Responsibility & Public Policy Committees. She is a member of the Sustainability and Innovation Committee.
    Mr Peter Possemiers Non-Executive Director Nov 2022
    Mr Possemiers has a background as a TIC sector expert with almost 40 years of experience working as a senior executive in leadership roles globally for SGS. He has lead teams both regionally and globally most notably SGS's global Environment Health and Safety business, then a CHF 550 million business with a global headcount which exceeded 6000. As Executive Vice President, he was a member of the SGS Operations Council with responsibility for the strategic growth and profitability of the business, leading 15 strategic acquisitions. He moved into management roles in Singapore, Philippines, China and Korea, where he established and developed new markets including food, pharma, and mobile technology. In 2013, Peter was promoted to Executive Vice President, Global Environment, Health & Safety, a position based in Switzerland which he held for 8 years before moving into his most recent role as Vice President, Strategic Integration in 2021 following the acquisition of the Synlab A&S business, which covered the environmental, food, pharma and oil condition monitoring testing sector across Europe. He is the Chair of the People Committee, and a member of the Risk Committee.
    Mr Malcom Deane Chief Strategy Officer General Manager Life Sciences - Food & Pharma Americas GeneralChief Executive OfficerManaging Director Mar 2023
    Mr Deane has served the company in various executive positions for the past 10 years in such roles as General Manager for Life Sciences Latin America, Food & Pharma Americas, and most recently as the Chief Strategy Officer, leading corporate strategy, business development and acquisitions.
    Ms Catharine Farrow Non-Executive Director Mar 2025
    Dr Farrow is a director of Franco-Nevada and has more than 30 years of mining industry experience in all aspects of exploration, development, technical services, acquisitions, company building, operations, board governance and innovation/technology. Her experience ranges from the High Arctic to equatorial environments in base, critical and precious metals. Catharine Farrow also serves as a director of Eldorado Gold Corporation, is lead director of Aclara Resources Inc., and until November 2024, was on the Board of Centamin PLC. She is also active in the mining and technology industries in both public and private companies, and academia as President of FarExGeoMine Ltd., where she provides advisory support in technical, governance, innovation and technology, organizational structure and as an expert witness. Previously she had been COO of KGHM International and held various other executive roles in precursor companies from 2003 to 2012 including as Chief Technology Officer and Senior Vice President Corporate Development and Technical Services (including joint ventures, M&A opportunities, and strategy). She is a member of the Sustainability and Innovation Committee.
    Mr Michael Paul Pearson Company Secretary Dec 2017
    -
    Ms Dayna Field Company SecretaryGeneral Counsel Oct 2024
    -
    Stuart Hutton Chief Financial Officer
    -
    Michael Paul Pearson Company Secretary
    -
    Dayna Field Company SecretaryGeneral Counsel
    -
    Tim Kilmister GM Environmental
    -
    Andreas Jonsson GM Food & Pharma
    -
    Bruce McDonald GM Geochemistry
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 Shareholder 0 0.00%

    Profile

    since

    Note